Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc. Apr 21, 2023 11:55AM
Vallon Pharmaceuticals (VLON) and GRI Bio Enter into Merger Agreement Dec 13, 2022 04:06PM
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators Dec 13, 2022 04:05PM
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators Dec 13, 2022 04:05PM
Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results Nov 3, 2022 04:30PM


Nov 3, 2022 04:30PM Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results
Jul 28, 2022 08:00AM Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Jul 28, 2022 08:00AM Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
May 13, 2022 08:30AM Vallon Pharmaceuticals Inc. (VLON) Prices 3.7M Share Offering at $1.06/sh
May 13, 2022 08:30AM Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
May 13, 2022 08:30AM Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
May 9, 2022 04:05PM Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 9, 2022 04:05PM Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Apr 22, 2022 08:02AM Vallon Pharmaceuticals Inc. (VLON) Announces Review of Strategic Alternatives
Apr 22, 2022 08:00AM Vallon Pharmaceuticals Announces Review of Strategic Alternatives
Apr 22, 2022 08:00AM Vallon Pharmaceuticals Announces Review of Strategic Alternatives